#USA #Milford #Waters Corporation #Halo Labs #Biopharma Technology

Waters Corporation Acquires Halo Labs to Enhance Biological Analysis

Waters Corporation, a leader in analytical instrumentation, has announced its acquisition of Halo Labs™, an innovative provider of specialized imaging technologies. This strategic move aims to bolster Waters' portfolio in biological analysis, particularly in detecting and characterizing particles in therapeutic products such as cell, protein, and gene therapies.

Advances in Particle Analysis Technology

Halo Labs is renowned for its Aura™ platform, which offers differentiated technology capable of performing comprehensive particle analysis. This technology complements Waters' existing light scattering detection solutions, particularly those in the Wyatt Technology™ portfolio. Halo’s advanced capabilities allow for the detection of invisible particles, providing crucial insights during the characterization of external particles. These particles play a significant role in the enhancement of CAR-T cells used in cell therapy, marking a significant advancement in therapeutic products.

Dr. Udit Batra, President and CEO of Waters Corporation, expressed enthusiasm for the acquisition, stating, “By incorporating Halo Labs' innovative low-volume, high-throughput technology, we can analyze a wide range of sample types and sizes, enhancing our ability to generate insights early in the therapeutic development process and ensure greater manufacturing safety.” This integration not only provides a competitive edge in analytical technologies but also underlines Waters' commitment to investing in innovations that meet customer needs in the rapidly evolving biopharmaceutical landscape.

A Shared Vision for Innovation

Rick Gordon, CEO of Halo Labs, shared his excitement about collaborating with Waters, highlighting their shared values of targeted innovation and customer orientation. He remarked, “This combination accelerates our vision to broaden the reach of our platform, improving the development and production of therapeutics while maintaining our unwavering commitment to the quality and safety of medicines.” Gordon anticipates that this partnership will lead to groundbreaking progress that will benefit patients globally.

Minimal Immediate Financial Impact

The acquisition is projected to have only a minor impact on Waters Corporation’s income statement over the next twelve months, making it a strategic long-term investment rather than a short-term financial burden. As Halo Labs continues to forge its path in the biopharmaceutical industry, the synergy created from this acquisition is expected to yield significant advancements in the analytical technologies required for new biopharma therapies.

Insights into Halo Labs

Halo Labs operates as a venture-funded company specializing in scientific instruments and consumables that provide high-throughput tools for the formulation, stability, and quality control of biopharmaceuticals. Utilizing advanced customized optics and imaging techniques, they offer unparalleled insights into drug products, which are critical for biopharmaceutical companies worldwide.

About Waters Corporation

Waters Corporation (NYSEWAT) has been a pioneer in analytical instruments and separation technologies for over 65 years, serving the life, materials, food, and environmental sciences sectors. The company is dedicated to ensuring drug effectiveness, food safety, and product quality, with a global workforce of more than 7,600 employees. By collaborating with customers across laboratories, manufacturing sites, and hospitals, Waters aims to accelerate the accessibility of groundbreaking science.

With the acquisition of Halo Labs, Waters Corporation not only enhances its technological offerings but also reinforces its position as a leader in specialized analytical technology for biopharmaceutical applications. The synergy between the two companies opens up new avenues for innovation and healthcare improvements, demonstrating a commitment to advancing science for the benefit of patients worldwide.